tradingkey.logo

Premier Inc

PINC

25.750USD

-0.670-2.54%
Close 09/19, 16:00ETQuotes delayed by 15 min
2.13BMarket Cap
104.87P/E TTM

Premier Inc

25.750

-0.670-2.54%

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated: 2025-09-19

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
19 / 207
Overall Ranking
65 / 4720
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Hold
Current Rating
25.714
Target Price
-2.67%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Premier, Inc. is a healthcare improvement company, uniting an alliance of over 4,350 United States hospitals and health systems and over 325,000 other providers and organizations to transform healthcare. Its segments include Supply Chain Services and Performance Services. The Supply Chain Services segment includes its group purchasing organization program, supply chain co-management, purchased services and direct sourcing activities. The Performance Services segment consists of three sub-brands: PINC AI, its technology and services platform, Contigo Health, its direct-to-employer business, and Remitra, its digital invoicing and payables automation business. It delivers a comprehensive technology-enabled platform that offers critical supply chain services, clinical, financial, operational and value-based care software as a service and clinical and enterprise analytics license, consulting services, performance improvement collaborative programs and third-party administrator services.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 124.13%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 124.13%.
Overvalued
The company’s latest PE is 115.90, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 80.42M shares, decreasing 19.65% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 9.79M shares of this stock.

Financial Health

Currency: USD Updated: 2025-09-19

The company's current financial score is 9.18, which is higher than the Healthcare Equipment & Supplies industry's average of 7.32. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 262.86M, representing a year-over-year decrease of 24.96%, while its net profit experienced a year-over-year decrease of 69.62%.

Score

Industry at a Glance

Previous score
9.18
Change
0

Financials

7.07

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data

Quality of Earnings

10.00

Operational Efficiency

10.00

Growth Potential

9.27

Shareholder Returns

9.57

Company Valuation

Currency: USD Updated: 2025-09-19

The company’s current valuation score is 6.24, which is higher than the Healthcare Equipment & Supplies industry's average of 3.59. Its current P/E ratio is 118.91, which is -81.61% below the recent high of 21.87 and 86.84% above the recent low of 15.64.

Score

Industry at a Glance

Previous score
6.24
Change
1.25

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 19/207
No Data

Earnings Forecast

Currency: USD Updated: 2025-09-19

The company’s current earnings forecast score is 5.75, which is lower than the Healthcare Equipment & Supplies industry's average of 7.70. The average price target for Premier Inc is 26.00, with a high of 28.00 and a low of 21.00.

Score

Industry at a Glance

Previous score
5.75
Change
0

Support & Resistance

No Data

Analyst Rating

Based on 8 analysts
Hold
Current Rating
25.714
Target Price
-2.67%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

118
Total
7
Median
8
Average
Company name
Ratings
Analysts
Premier Inc
PINC
8
Medtronic PLC
MDT
35
Stryker Corp
SYK
33
Abbott Laboratories
ABT
31
Zimmer Biomet Holdings Inc
ZBH
30
Dexcom Inc
DXCM
29
1
2
3
...
24

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2025-09-19

The company’s current price momentum score is 7.17, which is higher than the Healthcare Equipment & Supplies industry's average of 6.80. Sideways: Currently, the stock price is trading between the resistance level at 28.45 and the support level at 24.74, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
7.17
Change
-0.33

Support & Resistance

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(1)
Neutral(4)
Buy(0)
Indicators
Value
Direction
MACD(12,26,9)
-0.393
Neutral
RSI(14)
51.322
Neutral
STOCH(KDJ)(9,3,3)
20.096
Neutral
ATR(14)
0.815
High Vlolatility
CCI(14)
-90.847
Neutral
Williams %R
86.729
Oversold
TRIX(12,20)
0.427
Sell
StochRSI(14)
0.000
Oversold
Moving Average
Sell(3)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MA5
26.328
Sell
MA10
26.606
Sell
MA20
26.239
Sell
MA50
23.960
Buy
MA100
23.151
Buy
MA200
21.618
Buy

Institutional Confidence

Currency: USD Updated: 2025-09-19

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 6.89. The latest institutional shareholding proportion is 97.67%, representing a quarter-over-quarter decrease of 0.84%. The largest institutional shareholder is The Vanguard, holding a total of 9.79M shares, representing 11.86% of shares outstanding, with 1.35% decrease in holdings.

Score

Industry at a Glance

Previous score
10.00
Change
0

Institutional Shareholding

No Data

Shareholder Activity

Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
10.31M
-8.58%
The Vanguard Group, Inc.
Star Investors
10.19M
-7.61%
Dimensional Fund Advisors, L.P.
5.71M
-2.98%
State Street Global Advisors (US)
3.62M
-5.04%
American Century Investment Management, Inc.
2.89M
+11.27%
Brandes Investment Partners, L.P.
Star Investors
2.44M
+189.59%
Geode Capital Management, L.L.C.
1.69M
+1.68%
Charles Schwab Investment Management, Inc.
1.90M
+4.63%
LSV Asset Management
1.39M
+9.21%
1
2

Risk Assessment

Currency: USD Updated: 2025-09-19

The company’s current risk assessment score is 5.63, which is higher than the Healthcare Equipment & Supplies industry's average of 3.87. The company's beta value is 0.61. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.

Score

Industry at a Glance

Previous score
5.63
Change
0
Beta vs S&P 500 index
0.61
VaR
+2.08%
240-Day Maximum Drawdown
+25.19%
240-Day Volatility
+32.18%
Return
Best Daily Return
60 days
+7.29%
120 days
+11.85%
5 years
+13.29%
Worst Daily Return
60 days
-2.52%
120 days
-2.52%
5 years
-19.31%
Sharpe Ratio
60 days
+3.03
120 days
+2.62
5 years
+0.00
Risk Assessment
Maximum Drawdown
240 days
+25.19%
3 years
+50.50%
5 years
+57.97%
Return-to-Drawdown Ratio
240 days
+1.44
3 years
-0.11
5 years
-0.09
Skewness
240 days
+0.59
3 years
-1.56
5 years
-1.32
Volatility
Realised Volatility
240 days
+32.18%
5 years
+28.95%
Standardised True Range
240 days
+2.06%
5 years
+2.52%
Downside Risk-Adjusted Return
120 days
+733.71%
240 days
+733.71%
Maximum Daily Upside Volatility
60 days
+33.10%
Maximum Daily Downside Volatility
60 days
+19.60%
Liquidity
Average Turnover Rate
60 days
+2.27%
120 days
+2.04%
5 years
--
Turnover Deviation
20 days
+65.97%
60 days
+63.34%
120 days
+46.98%

Peer Comparison

Healthcare Equipment & Supplies
Premier Inc
Premier Inc
PINC
7.50 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Insulet Corp
Insulet Corp
PODD
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
STERIS plc
STERIS plc
STE
8.33 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Stevanato Group SpA
Stevanato Group SpA
STVN
8.24 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Abbott Laboratories
Abbott Laboratories
ABT
8.13 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Transmedics Group Inc
Transmedics Group Inc
TMDX
8.01 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI